We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EFPIA Lays Out Biosimilars Competition Plan to Sustain Industry With Incentives
EFPIA Lays Out Biosimilars Competition Plan to Sustain Industry With Incentives
With a growing number of biologics set to lose patent protection in coming years, a leading industry group is calling for regulatory reforms to encourage the development and approval of biosimilars.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor